98 related articles for article (PubMed ID: 19242522)
1. Bcl-xL gene expression correlated with lower apoptotic cell numbers and shorter progression-free survival in PCFCL.
Soltani-Arabshahi R; Leboeuf C; Rivet J; Pisonero H; Zhao WL; Bachelez H; Ameisen JC; Janin A
J Invest Dermatol; 2009 Jul; 129(7):1703-9. PubMed ID: 19242522
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.
Zhao WL; Daneshpouy ME; Mounier N; Brière J; Leboeuf C; Plassa LF; Turpin E; Cayuela JM; Ameisen JC; Gisselbrecht C; Janin A
Blood; 2004 Jan; 103(2):695-7. PubMed ID: 12969962
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions.
Pham-Ledard A; Cowppli-Bony A; Doussau A; Prochazkova-Carlotti M; Laharanne E; Jouary T; Belaud-Rotureau MA; Vergier B; Merlio JP; Beylot-Barry M
Am J Clin Pathol; 2015 Mar; 143(3):362-73. PubMed ID: 25696794
[TBL] [Abstract][Full Text] [Related]
4. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract][Full Text] [Related]
5. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Sharma H; Sen S; Mathur M; Bahadur S; Singh N
Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy induced changes in apoptosis and its major regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced invasive squamous cell carcinoma of the cervix.
Adhya AK; Srinivasan R; Patel FD
Int J Gynecol Pathol; 2006 Jul; 25(3):281-7. PubMed ID: 16810067
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.
Cao XX; Mohuiddin I; Ece F; McConkey DJ; Smythe WR
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):562-8. PubMed ID: 11713097
[TBL] [Abstract][Full Text] [Related]
10. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
Rassidakis GZ; Sarris AH; Herling M; Ford RJ; Cabanillas F; McDonnell TJ; Medeiros LJ
Am J Pathol; 2001 Aug; 159(2):527-35. PubMed ID: 11485911
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and expression of Bcl-2, Bcl-XL, and Bax in renal cell carcinomas.
Gobé G; Rubin M; Williams G; Sawczuk I; Buttyan R
Cancer Invest; 2002; 20(3):324-32. PubMed ID: 12025227
[TBL] [Abstract][Full Text] [Related]
13. Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma.
Sharma J; Srinivasan R; Majumdar S; Mir S; Radotra BD; Wig JD
Pancreas; 2005 May; 30(4):337-42. PubMed ID: 15841044
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
[TBL] [Abstract][Full Text] [Related]
15. BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia.
Gonzalez MS; De Brasi CD; Bianchini M; Gargallo P; Moiraghi B; Bengió R; Larripa IB
Blood Cells Mol Dis; 2010 Oct; 45(3):192-6. PubMed ID: 20728382
[TBL] [Abstract][Full Text] [Related]
16. [BCL-XL expression and mutation in non-Hodgkin's lymphoma].
Liu YH; Leboeuf C; Jin XL; Xiao JC; Janin A; Chen SJ; Zhao WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):903-7. PubMed ID: 17096886
[TBL] [Abstract][Full Text] [Related]
17. Estimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancer.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Korobowicz E; Korszen-Pilecka I; Zdunek M
Lung Cancer; 2006 Jan; 51(1):61-9. PubMed ID: 16297499
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2 and bcl-X in bladder cancer.
Kirsh EJ; Baunoch DA; Stadler WM
J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases.
Olopade OI; Adeyanju MO; Safa AR; Hagos F; Mick R; Thompson CB; Recant WM
Cancer J Sci Am; 1997; 3(4):230-7. PubMed ID: 9263629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]